#iDR26 International Drug Repurposing Conference 2026
Plenty of repeat iDR attendees gathered alongside some fresh new faces, with 504 of those joining experiencing their first iDR conference. This global event brought together key opinion leaders, researchers and patient advocates to collectively drive innovation in drug repurposing across Europe and beyond.
Beacon led sessions including Rare I – When is repurposing right for rare diseases, Rare II- New approaches to drive repurposing research in rare diseases, Community I – The community in action, which featured six lightning talks, and the Patient Engagement Panel – Having a drug isn’t enough.
When repurposing is right for rare diseases
Drug repurposing for industry
The role of AI in drug repurposing
New approaches to drive repurposing research in rare diseases
Hear from attendees about what made the conference so special
With thanks to:
We’re incredibly grateful to REMEDi4ALL for co-organising #iDR26 with us, and to the European Union for funding this project through the Horizon Europe Research & Innovation programme.
We would also like to thank our gold sponsors ZonMw and Dompé, bronze sponsor LifeArc, exhibitor sponsor Dendrite Clinical Systems LTD., and our Funders Network Collaborative Sponsorship with Cure Parkinson’s, ReumaNederland, Kaertor Foundation, Medac, Tarnagulla Ventures and Anticancer Fund, for their invaluable contributions to making #iDR26 a success.